INOCARDIA LIMITED
Significant control: Professor Helen Maddock (25–50%), Coventry University Enterprises Ltd (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Inocardia Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Inocardia Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
INOCARDIA LIMITED is an active private limited company (company number 08573417) incorporated on 18 June 2013, registered in Coventry. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 September 2025, showing net assets of £192k and cash of £39k, with 2 employees on average. Net assets fell 38% on the prior period (£311k).
By net assets it sits in the top quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Professor Helen Maddock
- owns 25–50% of shares
- holds 25–50% of voting rights
- Coventry University Enterprises Ltd
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mercia Technologies Plc
- owns 50–75% of shares
- holds 50–75% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 18 June 201313 yrs ago
- Next accounts due
- 30 June 2027in 247 days
- Confirmation statement due
- 2 July 2027in 249 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £192k | £39k | £3,075 | £351k | — | — | 2 |
| 30 September 2024 | £311k | £51k | £2,062 | £341k | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £191,522 at 30 September 2025
- Net assets down 25% or more on the prior period-38.3% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.12
- Incorporated five or more years agoIncorporated 18 June 2013
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 249 days
- Next accounts duein 247 days
- Accounts period endNet assets £192k · small accounts
- Accounts period endNet assets £311k · small accounts
- Incorporated
Similar companies in Coventry
- PHARMALOGOS LIMITEDStratford-Upon-Avon · inc. Sept 2012
- MEDHERANT LIMITEDCoventry · inc. Apr 2014
- LAKSHMI SOLUTIONS LIMITEDRugby · inc. Apr 2015
- ANTIMICROBIAL DISCOVERY SOLUTIONS LIMITEDWarwick · inc. Jun 2015
- NEUROSOLUTIONS THERAPEUTICS LIMITEDCoventry · inc. May 2011
- CELIXIR LIMITEDStratford-Upon-Avon · inc. Apr 2016
All companies incorporated on 18 June 2013 · in Jun 2013.
Reminders for INOCARDIA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.